LONDAMOCITINIB

UNII:	JAC34RRR7S
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₈H₃₁F₂N₇O₄S
Preferred Substance Name:	LONDAMOCITINIB
InChIKey:	JNUZADQZHYFJGW-JOCHJYFZSA-N
GSRS Full Record:	JAC34RRR7S i

2241039-81-4
(2R)-N-(3-{5-fluoro-2-[2-fluoro-3-(methanesulfonyl)anilino]pyrimidin-4-yl}-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide
(2R)-N-[3-[5-fluoro-2-(2-fluoro-3-methylsulfonylanilino)pyrimidin-4-yl]-1H-indol-7-yl]-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide
(R)-N-(3-(5-Fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide
1-Piperazineacetamide, N-[3-[5-fluoro-2-[[2-fluoro-3-(methylsulfonyl)phenyl]amino]-4-pyrimidinyl]-1H-indol-7-yl]-α-(methoxymethyl)-4-methyl-, (αR)-
AZD-4604
AZD4604
LONDAMOCITINIB [USAN]
Londamocitinib
Londamocitinib [WHO-DD]
londamocitinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LONDAMOCITINIB

Synonyms and Mappings

Resources